P63873 (CYSM_MYCTU) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 52.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: O-phosphoserine sulfhydrylase Short name=OPS sulfhydrylase EC=2.5.1.65 EC=2.5.1.n5 Alternative name(s): CysO-thiocarboxylate-dependent cysteine synthase Cysteine synthase B Short name=CSase B O-phosphoserine-specific cysteine synthase | ||||||
| Gene names |
| ||||||
| Organism | Mycobacterium tuberculosis | ||||||
| Taxonomic identifier | 1773 [NCBI] | ||||||
| Taxonomic lineage | Bacteria › Actinobacteria › Actinobacteridae › Actinomycetales › Corynebacterineae › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis complex |
Protein attributes
| Sequence length | 323 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Catalyzes the formation of a covalent CysO-cysteine adduct via a sulfur transfer, using the thiocarboxylated sulfur carrier protein CysO-COSH as sulfur donor and O-phospho-L-serine (OPS) as sulfur acceptor. Can also use sodium sulfide as sulfur donor in vitro, albeit with less efficiency, but not thiosulfate or thio-nitro-benzoate. O-acetylserine (OAS) is a very poor substrate in comparison with OPS. May be of particular importance for cysteine biosynthesis in the persistent phase of M.tuberculosis. Ref.5 Ref.7 |
| Catalytic activity | O-phospho-L-serine + H2S = L-cysteine + phosphate. Ref.5 Ref.7 Ref.8 O-phospho-L-serine + [CysO]-SH = [CysO]-L-cysteine + phosphate. Ref.5 Ref.7 Ref.8 |
| Cofactor | Pyridoxal phosphate. Ref.7 |
| Pathway | |
| Subunit structure | Homodimer. Ref.7 |
| Induction | Up-regulated under oxidative stress conditions. Ref.3 |
| Domain | The five C-terminal amino acid residues are inserted into the active site cleft in the closed conformation, protect the aminoacrylate intermediate and are involved in sulfur donor selectivity. Ref.8 |
| Disruption phenotype | Strains lacking this gene are shown to be attenuated in macrophages. Ref.4 |
| Sequence similarities | Belongs to the cysteine synthase/cystathionine beta-synthase family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Amino-acid biosynthesis Cysteine biosynthesis |
| Ligand | Pyridoxal phosphate |
| Molecular function | Transferase |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | cysteine biosynthetic process from serine Inferred from direct assay Ref.7. Source: MTBBASE |
| Cellular component | cytosol Traceable author statement. Source: Reactome protein complexInferred from direct assay Ref.6. Source: MTBBASE |
| Molecular function | O-phosphoserine sulfhydrylase activity Inferred from direct assay Ref.7. Source: MTBBASE cysteine synthase activityInferred from electronic annotation. Source: InterPro protein homodimerization activityInferred from physical interaction Ref.7. Source: MTBBASE pyridoxal phosphate bindingInferred from direct assay Ref.7. Source: MTBBASE |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 323 | 323 | O-phosphoserine sulfhydrylase | PRO_0000167112 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 184 – 188 | 5 | Pyridoxal phosphate binding | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 81 | 1 | Pyridoxal phosphate | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 220 | 1 | Substrate Probable | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 265 | 1 | Pyridoxal phosphate | |||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 51 | 1 | N6-(pyridoxal phosphate)lysine | |||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 220 | 1 | R → A: 700-fold decrease in the rate of the first half-reaction using OPS. Affects neither the rate of the first half-reaction using OAS nor the rate of the second half-reaction using sulfide or CysO-COSH. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 319 – 323 | 5 | Missing: Decreased lifetime of the alpha-aminoacrylate reaction intermediate, increased susceptibility to oxidation by oxidative agents such as hydrogen peroxide, and partial loss of selectivity towards CysO-COSH as sulfur donor. Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 8 – 10 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 20 – 22 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 23 – 26 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 35 – 41 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 52 – 64 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 73 – 77 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 85 – 92 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 96 – 105 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 107 – 115 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 119 – 123 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 131 – 142 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 155 – 162 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 168 – 172 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 178 – 181 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 195 – 199 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 204 – 210 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 233 – 235 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 237 – 242 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 245 – 257 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 269 – 273 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 287 – 293 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 299 – 302 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 310 – 317 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence." Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E., Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K. Barrell B.G.Nature 393:537-544(1998) [PubMed: 9634230] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: ATCC 25618 / H37Rv. |
| [2] | "Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains." Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O., Peterson J.D., DeBoy R.T., Dodson R.J., Gwinn M.L., Haft D.H., Hickey E.K., Kolonay J.F., Nelson W.C., Umayam L.A., Ermolaeva M.D., Salzberg S.L., Delcher A., Utterback T.R. Fraser C.M.J. Bacteriol. 184:5479-5490(2002) [PubMed: 12218036] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: CDC 1551 / Oshkosh. |
| [3] | "Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression." Manganelli R., Voskuil M.I., Schoolnik G.K., Dubnau E., Gomez M., Smith I. Mol. Microbiol. 45:365-374(2002) [PubMed: 12123450] [Abstract] Cited for: INDUCTION. Strain: ATCC 25618 / H37Rv. |
| [4] | "Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages." Rengarajan J., Bloom B.R., Rubin E.J. Proc. Natl. Acad. Sci. U.S.A. 102:8327-8332(2005) [PubMed: 15928073] [Abstract] Cited for: DISRUPTION PHENOTYPE. Strain: ATCC 25618 / H37Rv. |
| [5] | "O-phospho-L-serine and the thiocarboxylated sulfur carrier protein CysO-COSH are substrates for CysM, a cysteine synthase from Mycobacterium tuberculosis." O'Leary S.E., Jurgenson C.T., Ealick S.E., Begley T.P. Biochemistry 47:11606-11615(2008) [PubMed: 18842002] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, KINETIC STUDIES, REACTION MECHANISM. |
| [6] | "Crystal structure of a sulfur carrier protein complex found in the cysteine biosynthetic pathway of Mycobacterium tuberculosis." Jurgenson C.T., Burns K.E., Begley T.P., Ealick S.E. Biochemistry 47:10354-10364(2008) [PubMed: 18771296] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF WILD-TYPE AND MUTANT ALA-204 IN COMPLEX WITH PYRIDOXAL PHOSPHATE AND PROTEIN CYSO, REACTION MECHANISM. |
| [7] | "Cysteine synthase (CysM) of Mycobacterium tuberculosis is an O-phosphoserine sulfhydrylase: evidence for an alternative cysteine biosynthesis pathway in mycobacteria." Agren D., Schnell R., Oehlmann W., Singh M., Schneider G. J. Biol. Chem. 283:31567-31574(2008) [PubMed: 18799456] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 3-323 IN COMPLEX WITH PYRIDOXAL PHOSPHATE, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBSTRATE SPECIFICITY, SUBUNIT, MUTAGENESIS OF ARG-220. Strain: ATCC 25618 / H37Rv. |
| [8] | "The C-terminal of CysM from Mycobacterium tuberculosis protects the aminoacrylate intermediate and is involved in sulfur donor selectivity." Agren D., Schnell R., Schneider G. FEBS Lett. 583:330-336(2009) [PubMed: 19101553] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 3-323 IN COMPLEX WITH PYRIDOXAL PHOSPHATE, CATALYTIC ACTIVITY, DOMAIN, MUTAGENESIS OF 319-GLY--ALA-323. Strain: ATCC 25618 / H37Rv. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | BX842576 Genomic DNA. Translation: CAA98100.1. AE000516 Genomic DNA. Translation: AAK45642.1. | ||||||||||||||||||||||||||||||
| PIR | D70771. | ||||||||||||||||||||||||||||||
| RefSeq | NP_215852.1. NC_000962.2. NP_335828.1. NC_002755.2. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P63873. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| EnsemblBacteria | EBMYCT00000001280; EBMYCP00000001280; EBMYCG00000001280. EBMYCT00000069828; EBMYCP00000067887; EBMYCG00000069823. | ||||||||||||||||||||||||||||||
| GeneID | 886867. 924673. | ||||||||||||||||||||||||||||||
| GenomeReviews | Gene locus MT1377 in contig AE000516_GR. Gene locus Rv1336 in contig AL123456_GR. | ||||||||||||||||||||||||||||||
| KEGG | mtc:MT1377. mtu:Rv1336. | ||||||||||||||||||||||||||||||
| PATRIC | 18124802. VBIMycTub22151_1516. | ||||||||||||||||||||||||||||||
| TIGR | MT1377. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| TubercuList | Rv1336. | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| GeneTree | EBGT00050000015764. | ||||||||||||||||||||||||||||||
| HOGENOM | HBG748215. | ||||||||||||||||||||||||||||||
| OMA | YSVGPRE. | ||||||||||||||||||||||||||||||
| PhylomeDB | P63873. | ||||||||||||||||||||||||||||||
| ProtClustDB | CLSK871928. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Reactome | REACT_27295. Mycobacterium tuberculosis biological processes. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR001216. Cys_synth_BS. IPR005856. Cys_synthKM. IPR001926. PyrdxlP-dep_enz_bsu. [Graphical view] | ||||||||||||||||||||||||||||||
| KO | K12339. | ||||||||||||||||||||||||||||||
| Pfam | PF00291. PALP. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SUPFAM | SSF53686. PyrdxlP-dep_enz_bsu. 1 hit. | ||||||||||||||||||||||||||||||
| TIGRFAMs | TIGR01136. CysKM. 1 hit. | ||||||||||||||||||||||||||||||
| PROSITE | PS00901. CYS_SYNTHASE. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | CYSM_MYCTU | ||||||||
| Accession | Primary (citable) accession number: P63873 Secondary accession number(s): Q10624 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Prokaryotic Protein Annotation Program | ||||||||
Relevant documents
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with